Pure Infusion Forms After Merger, Aims to Reshape Chronic Care

SANDY, UT – May 18, 2026 – A new major player has officially entered the U.S. healthcare landscape with the launch of Pure Infusion, a brand born from the strategic merger of AleraCare and Pure Healthcare. The unification creates a leading national provider of ambulatory infusion services, operating over 75 clinics across 14 states and serving more than 5,000 patients monthly. The company’s stated mission is to simplify the complex process of infusion therapy for chronic conditions while delivering a “patient-obsessed” experience that sets it apart from traditional hospital settings.

This launch marks the culmination of a merger completed on November 24, 2025, consolidating two established networks into a single, powerful entity. By combining clinical excellence with a highly streamlined operational model, Pure Infusion aims to tackle persistent challenges in healthcare: rising costs, administrative burdens for physicians, and inconsistent patient access to critical treatments.

“At Pure Infusion, we are redefining what patients and providers should expect from infusion care,” said Brady Porter, Chief Commercial Officer, in a statement. “Our new, unified brand reinforces this commitment and going forward we are deeply focused on further enhancing the core attributes both legacy organizations excelled at: providing exceptional clinical care, seamless coordination, and operating with a deeply human approach to every interaction.”

A New Force in a Consolidating Market

The formation of Pure Infusion is emblematic of a broader trend of consolidation within the fragmented ambulatory infusion center (AIC) market. The merger brings together AleraCare, which was backed by healthcare-focused private equity firm Hildred Capital Management, and Pure Healthcare, which was established by BUILD Capital Partners. The new company, led by CEO Joe Cosgrove, now stands as one of the largest dedicated AIC platforms in the country.

This consolidation provides significant scale, creating a formidable entity with enhanced leverage in negotiations with drug manufacturers and insurance payers. The move is strategically timed to capitalize on the ongoing shift of medical services away from costly inpatient hospital settings. Payers, including Medicare, Medicaid, and private insurers, are increasingly incentivizing the use of outpatient centers for regularly scheduled infusion therapies for conditions like Crohn's disease, multiple sclerosis, and rheumatoid arthritis, as they offer a more cost-effective site of care.

Pure Infusion’s new structure combines the strengths of its predecessors. AleraCare had a history of integration, having previously brought multiple specialty pharmacy and infusion companies under its banner. Pure Healthcare, meanwhile, was known for its successful Pure Infusion Suites, which focused on a high-end patient experience and had secured its own significant funding for national expansion. The combined platform now boasts a robust financial backing and a clear mandate for aggressive growth.

Redefining the Patient Experience

Central to Pure Infusion's brand identity is its “patient-obsessed” care model, which seeks to transform the often sterile and stressful experience of receiving intravenous therapy. The company has eschewed the traditional waiting room, instead offering patients private, spa-like treatment suites designed for comfort and privacy.

These suites come equipped with amenities such as comfortable recliners, personal streaming options for entertainment, and complimentary snacks and meals. This approach is more than just a luxury; it’s a strategic effort to improve patient adherence and quality of life. For individuals managing chronic illnesses that require regular, hours-long infusions, a comfortable and dignified environment can make a significant difference in their willingness to continue with prescribed treatment plans.

Beyond the physical environment, the operational model is built to eliminate friction. From the moment a provider sends a referral, dedicated regional teams of specialists take over. These teams handle the entire administrative workflow, including rapid intake processing, comprehensive insurance verification, pre-authorization management, and navigating financial assistance programs to lower out-of-pocket costs for patients. This streamlined process is designed to get patients started on therapy as quickly as possible, a critical factor in managing many progressive diseases. The model’s success is reflected in the high satisfaction scores of its legacy companies, with Pure Infusion Suites reporting an industry-leading Net Promoter Score of over 87 and accreditation from The Joint Commission, signaling a commitment to safety and quality.

Tackling Cost and Access in Chronic Care

By moving infusion services into a community-based ambulatory setting, Pure Infusion directly addresses two of the most pressing issues in modern healthcare: cost and access. Infusions administered in a hospital outpatient department can be significantly more expensive than the same treatment delivered in an independent AIC, a difference that impacts both payers and patients.

The company’s model provides a clear value proposition for the entire healthcare ecosystem. For patients, it offers a more convenient and affordable option closer to home, reducing travel time and financial strain. For referring physicians, it reduces administrative burdens, allowing them to focus on clinical care while a dedicated partner manages the complexities of infusion logistics. For payers, it represents a reliable way to lower the total cost of care for a high-cost patient population without sacrificing quality.

Pure Infusion’s growing national footprint across 14 states—from Alaska to Florida—is also a key component of its strategy to improve access. The organization can serve a diverse patient population across immunology, neurology, gastroenterology, and other specialties, creating a standardized, high-quality experience regardless of location. This broad network enables the company to form strategic partnerships with payers and pharmaceutical manufacturers to further streamline care delivery and ensure patients receive the therapies they need with minimal delay.

A Strategy for National Growth and Innovation

With the merger complete and the new brand launched, Pure Infusion is poised for continued expansion. The company’s leadership has signaled a clear intent to grow its geographic footprint and service lines, building upon its existing foundation of 75 clinics. This growth is supported by a clear investment in technology, including plans to deploy AI-enabled platforms to optimize scheduling, benefits verification, and the tracking of real-time clinical outcomes.

This focus on technology is expected to deliver a smarter and more personalized level of care coordination, further enhancing efficiency and the patient experience. By leveraging data and advanced platforms, the company aims to not only streamline its own operations but also provide valuable insights back to referring providers and payers, fostering a more collaborative and effective care continuum.

As Pure Infusion moves forward with the complex task of integrating its systems, branding, and culture, the healthcare industry will be watching closely. The organization's success will depend on its ability to deliver on its promise of a superior patient experience at scale while proving its model of high-quality, cost-effective care. With a strong financial foundation, a clear strategic vision, and a deep focus on the patient, Pure Infusion is well-positioned to become a transformative force in the management of chronic disease across the nation.